Tony W Ho
CIK 1713637 · Executive VP, Head of R&D · last filed 2024-06-13
Tony W Ho is an Executive VP, Head of R&D who has filed 22 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for ITOS, was dated Jun 13, 2024. Across all open-market trades the lifetime net is −$4.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.24M
3
22
-$4.52M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| iTeos Therapeutics, Inc. (ITOS) Delisted | Director | — | $10.15 | — | $0 | 5 | 2024-06-13 |
| CRSP | Executive VP, Head of R&D | 64,971 | $49.80 | $3.24M | -$4.52M | 16 | 2021-12-07 |
| CRISPR Therapeutics AG (PZRX) Delisted | See Remarks | — | — | — | $0 | 1 | 2017-08-02 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-13 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-07 | CRSP | Mixed | +14,060 | -$872.0K | EDGAR |
| 2021-10-18 | CRSP | Grant (A) | — | $0 | EDGAR |
| 2021-06-21 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-03 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-12 | CRSP | Mixed | +2,442 | -$265.8K | EDGAR |
| 2021-03-09 | CRSP | Mixed | +1,748 | -$181.7K | EDGAR |
| 2020-12-22 | CRSP | Mixed | — | -$3.12M | EDGAR |